A detailed history of Cutler Capital Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Cutler Capital Management, LLC holds 242,744 shares of PFE stock, worth $6.05 Million. This represents 3.78% of its overall portfolio holdings.

Number of Shares
242,744
Previous 237,144 2.36%
Holding current value
$6.05 Million
Previous $6.64 Million 5.88%
% of portfolio
3.78%
Previous 3.95%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$27.7 - $31.39 $155,120 - $175,784
5,600 Added 2.36%
242,744 $7.03 Million
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $126,704 - $148,473
5,016 Added 2.16%
237,144 $6.64 Million
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $193,320 - $221,993
7,467 Added 3.32%
232,128 $6.44 Million
Q4 2023

Feb 13, 2024

BUY
$26.13 - $33.94 $414,421 - $538,288
15,860 Added 7.6%
224,661 $6.47 Million
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $193,823 - $226,560
6,040 Added 2.98%
208,801 $6.93 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $1.64 Million - $1.9 Million
45,511 Added 28.94%
202,761 $7.44 Million
Q2 2023

Aug 11, 2023

SELL
$36.12 - $41.79 $489,317 - $566,129
-13,547 Reduced 7.93%
157,250 $5.77 Million
Q1 2023

May 12, 2023

BUY
$39.39 - $51.28 $824,196 - $1.07 Million
20,924 Added 13.96%
170,797 $6.97 Million
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $28,014 - $36,569
671 Added 0.45%
149,873 $7.68 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $19,473 - $23,771
445 Added 0.3%
149,202 $6.53 Million
Q2 2022

Aug 11, 2022

BUY
$46.53 - $55.17 $16,332 - $19,364
351 Added 0.24%
148,757 $7.8 Million
Q1 2022

May 11, 2022

SELL
$45.75 - $56.69 $105,545 - $130,783
-2,307 Reduced 1.53%
148,406 $7.68 Million
Q4 2021

Feb 09, 2022

SELL
$41.32 - $61.25 $109,993 - $163,047
-2,662 Reduced 1.74%
150,713 $8.9 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $70,650 - $90,756
1,800 Added 1.19%
153,375 $6.6 Million
Q2 2021

Aug 04, 2021

BUY
$35.91 - $40.68 $44,348 - $50,239
1,235 Added 0.82%
151,575 $5.94 Million
Q1 2021

Apr 22, 2021

BUY
$33.49 - $37.77 $842,775 - $950,482
25,165 Added 20.1%
150,340 $5.45 Million
Q4 2020

Jan 28, 2021

SELL
$33.47 - $42.56 $20,918 - $26,600
-625 Reduced 0.5%
125,175 $4.61 Million
Q3 2020

Nov 05, 2020

BUY
$31.75 - $37.25 $174,625 - $204,875
5,500 Added 4.57%
125,800 $4.62 Million
Q2 2020

Aug 12, 2020

SELL
$30.12 - $36.54 $36,144 - $43,848
-1,200 Reduced 0.99%
120,300 $3.93 Million
Q1 2020

May 12, 2020

BUY
$27.03 - $38.62 $94,605 - $135,170
3,500 Added 2.97%
121,500 $3.97 Million
Q4 2019

Feb 10, 2020

BUY
$32.92 - $37.36 $1.25 Million - $1.42 Million
38,000 Added 47.5%
118,000 $4.62 Million
Q3 2019

Nov 08, 2019

BUY
$32.49 - $42.13 $1.36 Million - $1.77 Million
42,000 Added 110.53%
80,000 $2.87 Million
Q1 2018

May 08, 2018

SELL
$31.91 - $37.02 $63,820 - $74,040
-2,000 Reduced 5.0%
38,000 $1.35 Million
Q4 2017

Feb 06, 2018

SELL
$33.26 - $35.29 $33,260 - $35,290
-1,000 Reduced 2.44%
40,000 $1.45 Million
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $1.27 Million - $1.4 Million
41,000
41,000 $1.46 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $140B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Cutler Capital Management, LLC Portfolio

Follow Cutler Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Capital Management, LLC with notifications on news.